Abvc Biopharma (ABVC) Other Operating Expenses (2010 - 2026)
Abvc Biopharma (ABVC) recorded Other Operating Expenses of $253,041 in Q2 2026, down 83.9% from $1.57 million a year earlier and down 67.9% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Other Operating Expenses (2010 - 2026) Analysis & Trends
On a TTM basis, Abvc Biopharma's Other Operating Expenses came in at $3.56 million as of Jun 30, 2026, up 71.3% year-over-year; for FY2025, it was $4.14 million, up 49.4% from FY2024.
- Annual Other Operating Expenses has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- Across earlier years, Other Operating Expenses came in at $2.77 million in FY2024, $185,933 in FY2023 (-97.4%), $7.04 million in FY2022 (+32.6%) and $5.31 million in FY2021 (+28.0%).
- The Q2 2026 figure is the lowest quarterly Other Operating Expenses since Q1 2025.
- On a year-over-year basis, Other Operating Expenses rose in two of the last five quarters, with growth averaging 93.5%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 728.4% in Q1 2023, against a decline of 97.6% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $787,374 (Q1 2026), $1.39 million (Q4 2025) and $1.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253,041.00 |
| Mar 31, 2026 | 787,374.00 |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 48,773.00 |
| Dec 31, 2024 | 363,079.00 |
| Sep 30, 2024 | 95,875.00 |
| Jun 30, 2024 | 282,875.00 |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Sep 30, 2023 | 817,740.00 |
| Jun 30, 2023 | 225,740.00 |
| Mar 31, 2023 | 366,489.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 225,740.00 |
| Jun 30, 2022 | 225,740.00 |
| Mar 31, 2022 | 44,239.00 |
| Dec 31, 2021 | 4.38 Mn |
| Sep 30, 2021 | 225,740.00 |
API Access
Abvc Biopharma Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();